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Introduction
Biological aging involves complex dysfunctional cellular processes with unclear underlying mecha-
nisms, including a potential involvement of  alterations at the nuclear level in a wide range of  tissues 
(1). Normal nuclear function requires lamin A, a protein located at the inner nuclear envelope, where 
it regulates nuclear integrity, architecture, and chromatin organization (2). Defective processing of  
lamin A and accumulation of  its precursors, progerin and/or prelamin A, occurs during physiological 
aging (3, 4) and is also responsible for premature aging syndromes (2, 5). Symptoms include growth 
impairment, bone and skin abnormalities, joint contractures, and muscle dysfunction. In the present 
study, we aimed to determine whether and how high levels of  prelamin A deteriorate the function of  
skeletal muscle fibers.
Myofibers contain several hundred peripherally located nuclei. Each of  them controls protein syn-
thesis in a defined volume of  cytoplasm termed the myonuclear domain (MND). Regular positioning 
of  these nuclei is essential for optimal nuclear cooperation, MND size, and efficient regulation and 
distribution of  gene products (6). Here, we tested the hypothesis that an accumulation of  prelamin 
A would alter nuclear number and positioning, ultimately disrupting the ability of  fibers to generate 
force. To test this, we used various transgenic mouse models that mimic premature aging syndromes, 
wherein the composition of  nuclear envelope proteins is altered. We isolated and membrane-permea-
bilized individual muscle fibers, then ran a series of  contractile and morphological analyses, including 
an evaluation of  the 3D organization of  nuclei, using our image analysis algorithm applied to recon-
structed confocal images (7).
Physiological and premature aging are frequently associated with an accumulation of prelamin A, a 
precursor of lamin A, in the nuclear envelope of various cell types. Here, we aimed to underpin the 
hitherto unknown mechanisms by which prelamin A alters myonuclear organization and muscle 
fiber function. By experimentally studying membrane-permeabilized myofibers from various 
transgenic mouse lines, our results indicate that, in the presence of prelamin A, the abundance of 
nuclei and myosin content is markedly reduced within muscle fibers. This leads to a concept by 
which the remaining myonuclei are very distant from each other and are pushed to function beyond 
their maximum cytoplasmic capacity, ultimately inducing muscle fiber weakness.
2insight.jci.org   https://doi.org/10.1172/jci.insight.120920
R E S E A R C H  A R T I C L E
Results
Zmpste24-deficient mice represent a valuable animal model of  premature/disease-induced aging, as they 
lack zinc metallopeptidase STE24 (Zmpste24) enzyme (8–10), which is responsible for the processing of  
prelamin A. As a consequence, these animals accumulate unprocessed prelamin A in their nuclei, mimick-
ing human progeria syndromes (Figure 1).
Myofibers lacking Zmpste24 have impaired nuclear number, MND size, and protein content. Muscle fibers and 
nuclei are commonly analyzed using muscle cross sections. This methodological approach has numerous 
limitations and does not allow accurate enumeration of  nuclei or their distribution within fibers, as only 2 
dimensions are visualized unless multiple sections are studied. To address this, we isolated 97 individual 
myofibers and analyzed confocal reconstructions in 3D (Figure 2A). Our data showed that the overall 
number of  nuclei per millimeter fiber length was significantly lower in mice lacking Zmpste24 than in WT 
animals (Figure 2B).
As observed previously in WT animals (7), the number of  nuclei per millimeter fiber length and aver-
age MND size positively and linearly related to their fiber cross-sectional area (CSA) (Figure 2, B and C). 
However, in Zmpste24-deficient mice, as the number of  nuclei per millimeter fiber length did not increase 
with fiber CSA (Figure 2B), the MND volume was significantly greater than in WT rodents, with larger 
fibers being more severely affected (Figure 2C). MND measurements provide valuable information about 
the average volume of  cytoplasm controlled by each myonucleus; however, they do not allow characteriza-
tion of  the overall spatial arrangement/organization of  myonuclei within the whole fiber. To evaluate this 
parameter, we started by calculating nearest neighbor (NN) distances using the 3D coordinates of  individ-
ual nuclei within each single fiber. In WT mice, NN distance was unrelated to CSA and remained constant 
at ~34 μm (Figure 2D). On the other hand, NN distance was significantly dependent on CSA in Zmp-
ste24-deficient animals (Figure 2D), supporting once again the notion that larger fibers are more severely 
affected. To further assess the regularity of  nuclear positioning within muscle fibers, a distribution or order 
score (g) was calculated as described previously (11). Interestingly, this parameter was not affected by the 
absence of  Zmpste24 (Figure 2E), implying that a regular nuclear spacing is maintained despite differences 
in nuclear number, MND, and NN distance.
Such nuclear abnormalities could be accompanied by modified global gene transcription, since nuclear 
cooperation is known to be affected by nuclear spacing within muscle fibers (12). To address this possibil-
ity, we used acetyl-histone H3 (AcH3) and H3K27me3 as markers of  global transcriptional activity. The 
intensity of  AcH3 within individual nuclei was significantly lower in mice lacking Zmpste24 than in WT 
animals (Figure 3B). Additionally, the mean positive AcH3 intensity (measured by setting a cutoff  point for 
nuclei above 500 Gy of  background level) was significantly reduced in Zmpste24-deficient compared with 
Figure 1. Prelamin A accumulation in Zmpste24-deficient myonuclei. Typical EDL myofibers immunostained for nuclei 
(blue) and prelamin A (green). WT refers to 4-month-old WT mice, while Zmpste24 KO refers to age-matched homo-
zygous Zmpste24-deficient mice. Images were taken using a ×20 objective, apart from the inset (×100 objective). Note 
that all the nuclei from Zmpste24 KO mice were prelamin A positive, while none of the WT nuclei exhibited prelamin A.
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WT counterparts (Figure 3C), resulting in a decreased total positive to negative AcH3 nuclear ratio (Figure 
3D). However, no significant differences were observed for H3K27me3 (Figure 3, E–G). Overall, these data 
suggest potential transcriptional alterations that may affect contractile protein synthesis and content. Indeed, 
we observed that the mean pixel intensity of  rhodamine phalloidin within individual myofibers was lower 
in the absence of  Zmpste24 (Figure 3A). To support our interpretation of  these data, we ran a proteomics 
analysis (TMT6plex experiments) focusing on contractile proteins. The content of  myosin and total contrac-
tile proteins (including myosin; actin; tropomyosin; troponin I, C, and T) was lower in myofibers from mice 
lacking Zmpste24 when compared with fibers from WT mice, and this was dependent on fiber size, with a 
greater effect observed in fibers with larger cross-sectional area (Figure 4).
Together these results suggest that mechanisms related to (i) myonuclear number and (ii) contractile pro-
tein content are likely to be involved in the etiology of  muscle fiber dysfunction in the presence of  prelamin A.
Muscle fibers lacking Zmpste24 display reduced force production. To measure the force-generating capacity 
of  myofibers at the contractile level without the confounding effects of  possible disrupted sarcoplasmic 
reticulum Ca2+ handling or sarcolemmal excitability, we measured the absolute steady-state isometric force 
at saturating [Ca2+] (pCa 4.50) of  77 membrane-permeabilized fibers. Absolute force was strongly related to 
CSA, and a positive linear relationship was observed in WT mice (Figure 2F). However, such a relationship 
was nonexistent in mice lacking Zmpste24 (Figure 2F), demonstrating that larger fibers with disproportion-
ately greater MND sizes (and lower contractile protein content) were more severely impaired (Figure 2, C 
and F). Specific force, defined as absolute (maximal) force divided by CSA, was significantly lower in mice 
lacking Zmpste24 than in WT animals (Figure 2G). This force depression can be due to changes in the 
total number of  myosin molecules available, their recruitment upon Ca2+ activation and/or their intrinsic 
cycling and mechanical properties in binding to actin. To distinguish between these potential mechanisms, 
we started by measuring rigor force (maximum force in the absence of  ATP). This parameter was signifi-
cantly smaller in rodents lacking Zmpste24 than in WT mice (Figure 2H). As rigor force and specific force 
were depressed to a similar extent (Figure 2G), and as under rigor conditions, all myosin heads are attached 
because of  a very slow dissociation rate (13), we suggest that the Ca2+ recruitment of  myosin molecules 
is not affected in the presence of  prelamin A. In addition to measuring rigor force, we calculated the rate 
of  force development (ktr). Zmpste24 deficiency did not have any negative effect on this parameter (38.40 
± 3.00 s–1 for mice lacking Zmpste24 versus 39.10 ± 2.50 s–1 for WT mice). Taking into consideration that 
ktr depends on fapp + gapp, with fapp being the rate constant for attachment and gapp being the rate constant 
for detachment (14), the force depression in the presence of  prelamin A is not associated with significant 
changes in myosin cross-bridge cycling properties. Hence, the specific force depression is most likely related 
to a quantitative reduction in the content of  contractile proteins (total number of  myosin molecules avail-
able) observed in the Zmpste24 mutant mice (Figure 4).
Altogether, our findings unravel, for the first time to our knowledge, a potential link between subopti-
mal nuclear number and functional contractile efficiency of  muscle fibers.
Reducing the amount of  prelamin A in Zmpste24-deficient muscle fibers rescues nuclear arrangement and 
force-generating capacity. To support our proposal of  a direct correlation between myonuclear number and 
force production, we used two different approaches. First, we compared fibers from WT animals with 
those from Zmpste24 mosaic mice known to have equal proportions of  Zmpste24-deficient (prelamin 
A–accumulating) and Zmpste24-proficient (mature lamin A–containing) nuclei in their cells (15). Num-
ber of  nuclei per millimeter fiber length and specific force were similar in the 2 mouse lines (Figure 5). 
Second, we evaluated the effects of  a farnesyltransferase inhibitor (FTI; ABT-100) on the muscle fiber 
function of  Zmpste24-deficient mice (16). ABT-100 has previously been shown to block the farnesylation 
of  prelamin A, preventing its accumulation at the nuclear envelope level (16). As anticipated, myofibers 
from FTI-treated rodents exhibited rescued number of  nuclei, MND sizes, and force-generating capacity 
when compared with vehicle-treated animals (Figure 6).
Lamin A–deficient muscle fibers have subtle alterations in nuclear number but a normal ability to generate force. 
Prior work from our laboratory and by others has shown that Zmpste24-deficient mice display an accumula-
tion of  prelamin A and a deficiency of  lamin A (8, 9). Thus, the above results may originate from either of  
these two alterations or from both. To further investigate the effects of  a specific lamin A deficiency, without 
the confounding effects of  high levels of  prelamin A, we studied a transgenic mouse model lacking A-type 
lamins (lamin A and C) (17, 18) (Figure 7A). Even though myofibers from lamin A–deficient mice had a 
significantly lower number of  nuclei per millimeter fiber length than those from WT animals (Figure 7B), 
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Figure 2. Altered myonuclear organization and force production in the absence of Zmpste24. (A) Typical confocal images (×20 objective) of myo-
fibers from 4-month-old WT (n = 5 mice, n = 44 fibers) and homozygous Zmpste24-deficient (Zmpste24 KO, n = 5 mice, n = 53 fibers) mice. These 
fibers were stained for nuclei (DAPI, blue) and actin (rhodamine phalloidin [RP], red). In B–H, data are presented as mean ± SEM, and as scatter 
plots wherein individual points correspond to single muscle fibers. Statistical tests included normality tests, t tests, and Pearson’s product moment 
correlation (to evaluate linear relationships).
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Figure 3. Expression of acetyl-histone H3 (Lys9/Lys14) and actin (phalloidin) in muscle fibers lacking Zmpste24. Mean intensity of (A) actin (rhodamine 
phalloidin [RP]); (B–D) acetyl-histone H3 (AcH3); (E–G) H3K27me3 staining in nuclei from WT (n = 4, mice, n = 65 nuclei) and Zmpste24-deficient (Zmpste24 
KO, n = 4 mice, n = 46 nuclei) muscle fibers. Data are shown as mean ± SD with individual points being single myofibers. Statistical tests included normality 
tests and t tests. +ve, positive; –ve, negative.
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the regression lines of  the MND size–CSA and absolute force–CSA relationships were normal (Figure 7, 
C and F). Additionally, the order score (g) and intrinsic force-generating capacity did not differ between the 
genotypes (Figure 7, D, E, and G). Similar results were observed for mice accumulating progerin, which is a 
truncated form of  lamin A (Figure 8).
Taken together these results suggest that the observed defects in Zmpste24-deficient mice resulted 
primarily from an accumulation of  prelamin A rather than a lack of  lamin A/C and, strikingly, that 
the defects are not phenocopied by expression of  progerin, which like prelamin A retains a C-terminal 
CAAX domain that alters a number of  other functional parameters of  the intermediate filament protein.
Disruption of  nesprin-1, but not SUN1, leads to nuclear and force alterations similar to those in muscle fibers 
lacking Zmpste24. Since properties of  nuclei are known to be dependent on their membrane (19–22), 
we also examined mice with alterations in other linker of  nucleoskeleton and cytoskeleton (LINC) 
complex proteins, in particular SUN1 and nesprin-1 (located within the nuclear envelope). Mice lack-
ing SUN1 closely mirrored WT rodents (Figure 9). In contrast, mice lacking the KASH domain of  
nesprin-1 displayed changes similar to those in Zmpste24-deficient animals (Figure 10). In fact, we 
observed aberrant nuclear number–CSA (Figure 10B), MND size–CSA (Figure 10C), NN distance–
CSA (Figure 10D), and absolute force–CSA relationships (Figure 10F), as well as reductions in specif-
ic force (Figure 10G).
These findings demonstrate variabilities between LINC complex proteins in their determination of  
nuclear number, MND size, and cellular force generation. Future studies are now warranted to deci-
pher the exact mechanisms by which various nuclear envelope proteins specifically regulate (or not) the 
abundance of  myonuclei.
Figure 4. Reduced contractile proteins in the 
absence of Zmpste24. (A and B) This figure 
relates to the TMT6plex experiments. Data are 
presented as scatterplots, wherein individual 
points correspond to single muscle fibers (WT, 
n = 3 mice, n = 6 fibers; Zmpste24 KO, n = 3 
mice, n = 5 fibers). Statistical tests included 
normality tests and t tests.
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Figure 5. Restoration of myonuclear number and force generation when the number of Zmpste24-deficient nuclei decreases. (A) Typical confocal images 
(×20 objective) of myofibers from 2-month-old WT (n = 3 mice, n = 16 fibers) and mosaic mice exhibiting similar amounts of Zmpste24-deficient (prelamin 
A–accumulating) and Zmpste24-proficient (mature lamin A–containing) nuclei in their cells (n = 3 mice, n = 22 fibers). These fibers were stained for nuclei 
(DAPI, blue) and actin (rhodamine phalloidin [RP], red). In B–G, data are presented as mean ± SEM, and as scatter plots wherein individual points correspond 
to single muscle fibers. Statistical tests included normality tests, t tests, and Pearson’s product moment correlation (to evaluate linear relationships).
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Figure 6. Increases in myonuclear number and force production in response to a farnesyltransferase inhibitor treatment in Zmpste24-deficient mice. 
(A) Typical confocal images (×20 objective) of fibers from 4-month-old mice lacking Zmpste24 treated with a farnesyltransferase inhibitor (FTI, n = 2 mice, 
n = 36 fibers) or vehicle (Veh, n = 2 mice, n = 32 fibers). These fibers were stained for nuclei (DAPI, blue) and actin (rhodamine phalloidin [RP], red). In B–G, 
data are presented as mean ± SEM, and as scatter plots wherein individual points correspond to single muscle fibers. Statistical tests included normality 
tests, t tests, and Pearson’s product moment correlation (to evaluate linear relationships).
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Figure 7. Disrupted myonuclear spatial arrangement and contractility in absence of lamin A. (A) Typical confocal images (×20 objective) of muscle fibers from 
typical 5-week-old WT (n = 4 mice, n = 51 fibers) and homozygous lamin A–deficient (Lmna KO, n = 4 mice, n = 81 fibers) mice. These fibers were stained for 
nuclei (DAPI, blue) and actin (rhodamine phalloidin [RP], red). In B–G, data are presented as mean ± SEM, and as scatter plots wherein individual points corre-
spond to single muscle fibers. Statistical tests included normality tests, t tests, and Pearson’s product moment correlation (to evaluate linear relationships).
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Figure 8. Normal myonuclear arrangement and contractility in the presence of a truncated form of lamin A, progerin. (A) Typical confocal images (×20 
objective) of muscle fibers from typical 12-week-old WT (n = 4 mice, n = 21 fibers) and homozygous lamin A–deficient (Lmna G609G/G609G, n = 4 mice, n = 33 
fibers) mice. These fibers were stained for nuclei (DAPI, blue) and actin (rhodamine phalloidin [RP], red). In B–G, data are presented as mean ± SEM, and as 
scatter plots wherein individual points correspond to single muscle fibers. Statistical tests included normality tests, t tests, and Pearson’s product moment 
correlation (to evaluate linear relationships).
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Figure 9. Normal nuclear organization and force production in SUN1-deficient muscle fibers. (A) Typical confocal images (×20 objective) of myofibers from 
4-month-old WT (n = 4 mice, n = 39 fibers) and homozygous SUN1-deficient (SUN1 KO, n = 4 mice, n = 44 fibers) mice. These fibers were stained for nuclei 
(DAPI, blue) and actin (rhodamine phalloidin [RP], red). In B–G, data are presented as mean ± SEM, and as scatter plots wherein individual points correspond 
to single muscle fibers. Statistical tests included normality tests, t tests, and Pearson’s product moment correlation (to evaluate linear relationships).
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Figure 10. Changes in nuclear positioning and force generation when the KASH domain of nesprin-1 is lacking. (A) Typical confocal images (×20 objec-
tive) of myofibers from 3-month old WT (n = 4 mice, n = 42 fibers) and homozygous KASH domain of nesprin-1–deficient (Nesprin-1 ΔKASH, n = 4 mice, 
n = 35 fibers) mice. These fibers were stained for nuclei (DAPI, blue) and actin (rhodamine phalloidin [RP], red). In B–G, data are presented as mean ± 
SEM, and as scatter plots wherein individual points correspond to single muscle fibers. Statistical tests included normality tests, t tests, and Pearson’s 
product moment correlation (to evaluate linear relationships).
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Discussion
In the present work, we aimed to unravel the mechanisms by which prelamin A accumulation modifies 
muscle fiber function.
Suboptimal MND sizes. In the presence of  prelamin A, we observed a lower number of  nuclei along 
the length of  myofibers, together with an increase in NN distances and MND volumes. This decrease in 
nuclear number might be related to a change in nuclear turnover, whereby myonuclei are not incorporated 
as efficiently, or are extensively lost. Previous studies using the same mouse model lacking Zmpste24 have 
observed a defect in the process of  nuclear incorporation into myofibers, due to a reduction in the total 
muscle stem cell (satellite cell) pool, as well as lower rates of  proliferation and differentiation (23, 24). 
Overall, satellite cell activation and myoblast fusion with muscle fibers have been shown to be impaired 
when the nuclear envelope is altered (24–26), suggesting that a change in the rate of  nuclear incorporation 
might be the primary cause of  the low number of  nuclei in muscle fibers where prelamin A accumulates. 
Insufficient nuclear number may also be a mechanism whereby the myofibers of  Zmpste24-deficient mice 
cannot sustain fiber sizes as large as those of  WT mice. This hypothesis is supported by our proteomics 
data, which show reduced contractile protein content in the myofibers of  Zmpste24-deficient mice, partic-
ularly in larger fibers.
The maintenance of  nuclear number, NN distance, and MND size is a prerequisite for preserving 
the intrinsic force-generating capacity of  muscle fibers during pathophysiological conditions (27–29). 
Hence, the decrease in the number of  nuclei and concomitant increase in NN distance and MND vol-
ume in the presence of  prelamin A may explain the loss in specific force in membrane-permeabilized 
fibers (where neuromuscular junction, excitation-contraction coupling, and sarcoplasmic reticulum 
Ca2+ release are not involved). This is in accordance with a recent study investigating myonuclear orga-
nization and force production in transgenic mice lacking myostatin, which suggested that abnormally 
hypertrophied fibers were limited in their force production through the inability to maintain optimal 
MND sizes (29). The absence of  myostatin or Zmpste24 may then share similar cascades of  subopti-
mal or negative cellular events. A lower incorporation and/or increased loss of  myonuclei may require 
the remaining myonuclei to extend their individual influence to unusually large cytoplasmic volumes 
beyond their maximum functional capacity (physiological “ceiling”), preventing optimal distribution 
of  gene products and protein synthesis, and ultimately leading to a suboptimal density of  contractile 
proteins (i.e., myosin). Therefore, intrinsic myofiber force production is decreased, and this results in 
skeletal muscle weakness. Further supporting this interpretation, our results clearly show that specific 
force is preferentially reduced in larger myofibers with larger MND sizes and aberrant NN distances, 
and that this is concurrent with reduced contractile protein content in larger fibers. Even though we 
believe that these phenomena are crucial, other unknown factors may also contribute to defects in 
muscles expressing prelamin A.
Preserved nuclear distribution. As mentioned earlier, myonuclei are well known to be evenly spaced along 
the surface of  muscle fibers. Such distribution is crucial to facilitate lower cytosolic transport distances (11) 
and to favor a better control of  chromosomal architecture and transcriptional regulation (30). Interestingly, 
we found that the overall distribution of  nuclei was preserved in all models studied, implying that proper 
inter-nuclear communication is maintained (31).
What causes nuclear dysfunction? Our data on mice lacking lamin A/C tend to demonstrate that a defi-
ciency in this protein has different consequences for myonuclear behavior than Zmpste24 deficiency. This 
confirms our initial hypothesis that the presence of  prelamin A, rather than the absence of  lamin A/C, is 
the major determinant underlying the above changes in NN distance and MND size. In addition, mice with 
an accumulation of  progerin did not show significant defects, again suggesting that the effects are specific 
to the presence of  prelamin A, rather than other processed forms of  lamin A.
It is worth noting that mice lacking A-type lamins develop a muscular dystrophy phenotype, consistent 
with a wide range of  human LMNA mutations associated with this disease. Therefore, while both mice 
expressing prelamin A and those lacking A-type lamins have muscle defects, our findings indicate that the 
etiology of  muscle dysfunction may be different. In the absence of  A-type lamins, increased degeneration 
of  both myofibers and myonuclei has been observed (32, 33), in addition to differentiation defects (26), 
suggesting a combination of  factors distinct to those associated with expression of  prelamin A contribute 
to dysfunction. Further close comparison of  different mouse models with lamin A/C mutations will be 
required to delineate these differences.
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Conclusion. Prelamin A dysregulates myonuclear abundance, NN distance, MND size, and intrinsic 
force-generating capacity. This mechanism may contribute to muscle fiber weakness in premature aging 
syndromes related to prelamin A accumulation.
Methods
Animals. Various transgenic mouse models were used in the present study, i.e., Zmpste24-KO (9), Zmp-
ste24–/– HprtZ24/+ (referred to herein as mosaic) (15), lamin A–KO (34), lamin AG609G/G609G (referred to here-
in as lamin AG609G) (34, 35), SUN1-KO (36) mice, and mice with an ablation in the KASH domain of  
nesprin-1, which disrupts the insertion of  this protein into the nuclear membrane (referred to herein as 
nesprin-1 ΔKASH) (37). Corresponding age-matched WT siblings were also sacrificed, and fast-contracting 
extensor digitorum longus (EDL) skeletal muscles were dissected.
FTI. ABT-100 was mixed in drinking water containing 0.4% hydroxy methyl propyl cellulose and 1.0% 
ethanol at a concentration of  0.3 mg/ml, so as to deliver a dose of  39 mg/kg/d. The vehicle control consist-
ed of  drinking water with 0.4% hydroxy methyl propyl cellulose and 1.0% ethanol. Mice drank the vehicle 
or ABT-100 for 15 weeks starting at 5 weeks of  age before euthanization and muscle dissection (16).
Muscle fiber permeabilization. Muscle samples were placed in relaxing solution at 4°C. Bundles of  approx-
imately 50 myofibers were dissected free and then tied with surgical silk to glass capillary tubes at slightly 
stretched lengths. They were then treated with skinning solution (relaxing solution containing glycerol; 
50:50 v/v) for 24 hours at 4°C, after which they were transferred to –20°C. For long-term storage the mus-
cle bundles were treated with sucrose, a cryoprotectant, within 1–2 weeks (38), detached from the capillary 
tubes, snap frozen in liquid nitrogen-chilled propane, and stored at –80°C.
Single myofiber force production. On the day of  experiment, bundles were de-sucrosed and transferred to a 
relaxing solution, and single myofibers were dissected. They were then individually attached between con-
nectors leading to a force transducer (model 400A; Aurora Scientific) and a lever arm system (model 308B; 
Aurora Scientific). Sarcomere length was set to ≈2.50 μm and the temperature to 15°C (39–41). Fiber CSA 
was estimated from the width and depth, assuming an elliptical circumference. The absolute maximal iso-
metric force generation was calculated as the difference between the total tension in the activating solution 
(pCa 4.50) and the resting tension measured in the same myofiber while in the relaxing solution (pCa 9.0). 
Specific force was defined as absolute force divided by CSA. Note that myofibers included in the analysis (i) 
were able to sustain 3 consecutive maximum activations without any force depression >10%; and (ii) had 
preserved sarcomere structures after the 3 maximum activations.
Measurement of  the apparent rate constants of  force redevelopment (ktr) involved a mechanical slack-re-
stretch maneuver. Each fiber was transferred from the relaxing to activating solution and allowed to generate 
steady-state force. The fiber was then rapidly slackened (within 1–2 ms) by 25% of its original length, resulting 
in a rapid reduction in force to near zero. This was followed by a brief  period of  unloaded shortening (20 ms), 
after which the preparation was rapidly restretched to its original length (13). ktr was estimated by linear trans-
formation of  the half-time of  force redevelopment (ktr = 0.693/t1/2) as described previously (13) (Figure 11).
Solutions. Relaxing and activating solutions contained 4 mM Mg-ATP, 1 mM free Mg2+, 20 mM imid-
azole, 7 mM EGTA, 14.5 mM creatine phosphate, and KCl to adjust the ionic strength to 180 mM and pH 
to 7.0. The concentrations of  free Ca2+ were 10–9.00 M (relaxing solution) and 10–4.50 M (activating solution).
Nuclear organization of  single fibers. Single muscle fibers were dissected following the same procedure as 
above. Arrays of  approximately 9 myofibers were prepared at room temperature (RT). For each myofiber, 
both ends were clamped to half-split copper meshes designed for electron microscopy (SPI G100 2010C-
XA, width 3 mm), which had been glued to cover slips (Menzel-Gläser, 22 × 50 mm, thickness 0.13–0.16 
mm). For measurement of  nuclear coordinates, fibers were mounted at a fixed sarcomere length of  ≈2.20 
μm. This was a prerequisite for exact determination of  spatial organization of  nuclei, as it allowed accurate 
comparisons between myofibers (7, 29, 42).
At RT, arrays were fixed in 4% PFA for 10 minutes, washed 3 times in PBS, further permeabilized 
in 0.1% Triton-X100/PBS for 10 minutes, and subsequently subjected to actin staining (rhodamine-con-
jugated phalloidin at 1:100 in PBS, Molecular Probes, R415) and nuclear staining (DAPI at 1:1,000 in 
PBS, Molecular Probes, D3571). Images were acquired using a confocal microscope (Zeiss Axiovert 
200, objectives ×20, ×40, and ×100) equipped with a CARV II confocal imager (BD Biosciences). To 
visualize muscle fibers in 3D, stacks of  100 images were acquired (1 μm Z increments) and analyzed with 
a custom-made MATLAB (MathWorks) program. Membrane-permeabilized fibers did not display any 
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Pax7-positive satellite cells. It should be noted that, in order to measure how ordered the nuclear distri-
bution for a particular fiber was, the individual NN distances were calculated for the experimental data. 
Then, a theoretical optimal and a theoretical random distribution was simulated, based on fiber dimen-
sions and nuclear number. We denote the experimental, random, and optimal means by ME, MR and MO, 
respectively. An order-score, g (11), was then calculated as: g = (ME – MR)/(MO – MR).
Fluorescence labeling. Fibers were PFA-fixed and Triton-permeabilized as described above (Nuclear 
organization of  single fibers). Fibers were treated with mouse-on-mouse block (Vector Laboratories, BMK-
2202) for 1 hour, blocked in 10% goat serum in PBS (Sigma-Aldrich, G9023) for 30 minutes, and treated 
with primary antibodies diluted in goat serum blocking buffer. Prelamin A was visualized using as pri-
mary antibody Santa Cruz Biotechnology Inc. sc-6214, c-20 (secondary antibody: Alexa Fluor 488, Invi-
trogen, A-11078) and Pax7 using Developmental Studies Hybridoma Bank (DSHB) AB 528428 as pri-
mary antibody (secondary antibody: Alexa Fluor 488, Invitrogen, A-11001). Lamin A (Abcam, ab8980) 
and nesprin-1 (Abcam, ab192234) were matched with Alexa Fluor 488 and 594, respectively (Invitrogen, 
A-11001 and A-11012). Acetyl-histone H3 (Lys9/Lys14) antibody (Cell Signaling Technology, 9677) 
matched with Alexa Fluor 594, respectively (Invitrogen, A-11012).
LC-MS/MS identification and quantitative analysis of  protein. For preparation, 3-mm-long muscle fibers 
were dissected and their CSAs calculated as above. These fibers were then placed in tubes containing 
25 μl Tris-Triton lysis buffer (10mM Tris [pH 7.4], 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% 
Triton X-100, 10% glycerol, 0.1% SDS, 0.5% deoxycholate). Prior to enzymatic digestion and labeling, 
the samples were loaded into a stack gel for lysis buffer cleanup to eliminate chemical interference at 
the labeling stage and to compress the whole proteome into a single band. Sample volumes were dried 
by half  in a SpeedVac (Thermo Fisher Scientific) with the volume replaced by Laemmli buffer (2×) and 
boiled for 10 minutes at 96°C. Reduced samples were loaded onto a 10% Bis-Tris NuPAGE gel and 
resolved for 10 minutes (100 V; 59 mA; 6 W) to “stack” the whole sample into a single band. Protein 
bands were visualized using Imperial protein stain (Thermo Fisher Scientific).
For digestion and peptide labeling with tandem mass tag (TMT), in-gel reduction, alkylation, and diges-
tion with trypsin were performed on all the samples prior to subsequent isobaric mass tag labeling (43). Each 
sample was treated individually with labels added at a 1:1 ratio.
Figure 11. Measurement of the rate of force redevelopment. Original recordings for the calculation of the rate 
of force redevelopment. Length and force signals of myofibers from one 4-month-old WT animal and from one 
age-matched homozygous Zmpste24-deficient (Zmpste24 KO) mouse are shown. Note that the time to half force 
recovery was 16 ms for WT and 18 ms for Zmpste24 KO. Hence, the rate of force redevelopment was 43.30 s–1 for 
WT and 38.50 s–1 for Zmpste24 KO. Note also that the force recovery is close to 100% for these original recordings 
as well as for most of all the other myofibers.
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For LC-MS/MS tandem mass spectrometry, the combined TMT-labeled peptide samples were resuspend-
ed in a solution containing water:acetonitrile:trifluoroacetic acid (98%:2%:0.05%) and analyzed by LC-MS/
MS. Chromatographic separations were performed using an Ultimate 3000 UHPLC system (Thermo Fisher 
Scientific). A 10-μl injection of peptides was resolved by reversed phase chromatography on a 75-μm C18 
column (50 cm) using a 3-step linear gradient of acetonitrile in 0.1% formic acid. The gradient was delivered 
to elute the peptides at a flow rate of 250 nl/min over 120 minutes. The eluate was ionized by electrospray 
ionization using an Orbitrap Fusion Lumos (Thermo Fisher Scientific) operating under Xcalibur v4.1. The 
instrument was programmed to acquire in automated data-dependent switching mode. The selection of pre-
cursor ions was based on their intensity for sequencing by higher-energy C-trap dissociation (HCD) for peptide 
identification and reporter ion fragmentation. Selection of precursor ions was also based on their intensity 
for sequencing by HCD in a TopN method. The MS/MS analyses were conducted using higher than normal 
collision energy profiles that were chosen based on the mass-to-charge ratio (m/z) and the charge state of the 
peptide. To increase fragmented peptide coverage and reporter ion intensities, a further synchronous precursor 
scan (SPS) of the top 5 most intense peaks using MS3 (Thermo Fisher Scientific) was performed.
Database searching. Raw mass spectrometry data were processed into peak list files using Proteome Dis-
coverer (Thermo Fisher Scientific; v2.2). The raw data file was processed and searched using the Mascot 
search algorithm (v2.6.0; Matrix Science) and the SEQUEST search algorithm (44) against the current 
mouse database curated within UniProt (https://www.uniprot.org/).
Bioinformatics. Following processing with Proteome Discoverer, the result file was exported into Perseus 
(v1.6.3; http://www.perseus-framework.org) for qualitative and quantitative data analysis.
Statistics. Data are presented as mean ± SEM. Statistical analysis was performed using SPSS Statistics 
23 software (IBM) and included normality tests, as well as t tests, ANOVAs, and Pearson’s product moment 
correlation (to evaluate linear relationships). Statistical significance was set to P < 0.05.
Study approval. The Institutional Animal Care and Use Committees of  the University of  Minnesota, 
University of  Oviedo, University of  California Los Angeles, Buck Institute for Research on Aging, Univer-
sity of  Würzburg, and Northwestern University approved all animal procedures.
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